GlassScriptPhysician profile
Bruce Douglas Lawrence
NPI 1467482018
$420.30
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $63.30 · 2021: $84.09.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $267.40 | 2019-2021 | |
| Linvatec Corporation | $35.03 | 2021 | |
| Ethicon US, LLC | $33.57 | 2019 | |
| Pacira Therapeutics, INC. | $25.09 | 2020 | |
| Orthofix Medical, INC. | $24.66 | 2021 | |
| Bioventus LLC | $23.49 | 2019 | |
| Horizon Therapeutics Plc | $11.06 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.